A large-scale genetic analysis focused on self-reported nightmare frequency and diagnostic-level nightmare disorder. The study team performed a GWAS meta-analysis for NF in 207,243 individuals of European (EUR) ancestry and a separate GWAS in 1,136 African (AFR) ancestry participants. They also ran ND analyses using effective-sample-size meta-analysis across EUR (NEff = 28,501), AFR (NEff = 11,828), and Admixed American (NEff = 4,093) cohorts. Short statement of outcome: NF in the EUR sample showed a SNP-based heritability of 7.4% and produced 17 novel risk loci reported by the authors. By contrast, the ND meta-analysis did not yield genome-wide significant loci in the reported analyses.
Sentence variety is intentional. The investigators reported a substantial sample for the primary NF analysis. The preprint does not provide locus-level effect sizes or p-values in the abstract; those details are contained in the full manuscript and supplementary materials linked by the authors.
The authors examined shared genetic architecture between nightmares and other traits. Data indicated genetic correlations between NF (and ND where evaluated) and psychiatric disorders, explicitly including PTSD and major depressive disorder. These correlations suggest overlapping genetic influences, though the study team also observed that a considerable fraction of NF genetic variance remained unexplained by the modeled shared factor.
Mendelian randomization (MR) analyses were used to explore directional relationships. The study team reported MR results consistent with potential bidirectional causal relationships between NF and several psychiatric and sleep-related traits. The abstract does not list MR effect estimates or which specific sleep traits produced the strongest MR signals; the reader must consult the main text and supplemental tables for the full MR output and sensitivity analyses.
Gene-based and transcriptome-wide association analyses implicated pathways related to endolysosomal function and progranulin biology. The authors named TMEM106B and GRN among genes of interest. These genes are connected to lysosomal regulation and progranulin signaling; the study team interpreted them as candidates for molecular mechanisms that may influence nightmare susceptibility.
Cell-type enrichment analyses pointed to excitatory neurons in limbic structures — specifically the hippocampus and amygdala. The combination of endolysosomal/progranulin signals with limbic excitatory neuron enrichment presents a coherent biological direction: genetic variation affecting lysosomal or progranulin-related processes in limbic excitatory cells could plausibly modulate dreaming or emotional processing during sleep. The preprint provides these analytic outcomes but does not claim mechanistic proof; experimental follow-up will be required to test cell-specific functional effects.
The analysis drew on multiple large cohorts. The authors used data from the UK Biobank (application 41910), the VA Million Veteran Program, and the All of Us Research Program, plus previously published summary statistics for NF from a 2024 study. Summary statistics generated in this study will be made available via Figshare and dbGaP under accession phs001672; the preprint lists a Figshare DOI for data deposition.
Competing interests were declared: one author reported editorial work income and another reported industry consulting and stock holdings; all other authors reported no conflicts in the author declarations. The study team confirmed ethical approvals and participant consent where required and followed reporting guidelines.
Key limitations are explicitly documented. The article is a preprint and has not been peer-reviewed; users should not change clinical practice on this basis. The ND meta-analysis did not identify genome-wide significant loci, and the non-European ancestry samples were substantially smaller than the EUR cohort, limiting ancestry-specific inference. The abstract does not present locus-level statistics or MR effect sizes; researchers and clinicians who need those data should consult the full manuscript and supplementary material where summary statistics and code are to be shared.
Open questions remain. The preprint does not resolve how the implicated genes mechanistically alter dream content or arousal thresholds. It also does not establish which clinical subgroups (for example, PTSD-related nightmares versus primary nightmare disorder) drive the genetic signals. Replication in independent, peer-reviewed datasets and functional experiments in relevant cell types will be needed. The authors plan to deposit summary statistics, which will allow independent investigators to attempt replication and to run further causal inference and fine-mapping analyses.